the in-vitro antifungal activities of bay n 7133 , a new orally absorbed synthetic azole derivative against 364 strains of fungal pathogens were studied in direct comparison with another orally active azole compound ketoconazole , using an agar dilution procedure .
C0004504
azole
C0022625
ketoconazole